SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma

Kanako Nakamura, Masayuki Komatsu, Fumiko Chiwaki, Takashi Takeda, Yusuke Kobayashi, Kouji Banno, Daisuke Aoki, Teruhiko Yoshida, Hiroki Sasaki

Research output: Contribution to journalArticle

Abstract

Despite chemoradiotherapy being one of the most important modalities in advanced cervical cancer, there is a lack of both usable biomarkers to predict treatment outcome and of knowledge about the mechanism of refractoriness to the therapy. Here we identified a transcriptional factor Single-minded homolog 2 (SIM2) as an independent predictive biomarker for uterine cervical squamous cell carcinoma (CvSCC). The retrospective study showed that high expression level of SIM2 was correlated to good survival in CvSCC patients. SIM2 knockdown in CvSCC cell lines showed resistance to hypoxia with increased expression of HIF1A and its target genes. Loss of SIM2 also caused growth promotion, resistance to ROS, and radiation in 3D culture. Furthermore, SIM2 knockdown suppressed tumor growth with increased HIF-1α expression and angiogenesis in vivo. On the other hand, SIM2 long isoform (SIM2l)-overexpressed cells had contrary results, indicating the long isoform plays a key role for maintenance of these phenotypes. These data indicated that SIM2l has a potential to be precision medicine for CvSCC patients and that anti-angiogenesis therapy might be usable for SIM2lLow poor survivors.

Original languageEnglish
Article number14574
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Squamous Cell Carcinoma
Protein Isoforms
Growth
Biomarkers
Precision Medicine
Chemoradiotherapy
Uterine Cervical Neoplasms
Survivors
Retrospective Studies
Maintenance
Radiation
Phenotype
Cell Line
Survival
Tumor Hypoxia
Therapeutics
Genes
Neoplasms

ASJC Scopus subject areas

  • General

Cite this

SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma. / Nakamura, Kanako; Komatsu, Masayuki; Chiwaki, Fumiko; Takeda, Takashi; Kobayashi, Yusuke; Banno, Kouji; Aoki, Daisuke; Yoshida, Teruhiko; Sasaki, Hiroki.

In: Scientific Reports, Vol. 7, No. 1, 14574, 01.12.2017.

Research output: Contribution to journalArticle

Nakamura, Kanako ; Komatsu, Masayuki ; Chiwaki, Fumiko ; Takeda, Takashi ; Kobayashi, Yusuke ; Banno, Kouji ; Aoki, Daisuke ; Yoshida, Teruhiko ; Sasaki, Hiroki. / SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{86a47c196f9b4880904f0b37d187671e,
title = "SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma",
abstract = "Despite chemoradiotherapy being one of the most important modalities in advanced cervical cancer, there is a lack of both usable biomarkers to predict treatment outcome and of knowledge about the mechanism of refractoriness to the therapy. Here we identified a transcriptional factor Single-minded homolog 2 (SIM2) as an independent predictive biomarker for uterine cervical squamous cell carcinoma (CvSCC). The retrospective study showed that high expression level of SIM2 was correlated to good survival in CvSCC patients. SIM2 knockdown in CvSCC cell lines showed resistance to hypoxia with increased expression of HIF1A and its target genes. Loss of SIM2 also caused growth promotion, resistance to ROS, and radiation in 3D culture. Furthermore, SIM2 knockdown suppressed tumor growth with increased HIF-1α expression and angiogenesis in vivo. On the other hand, SIM2 long isoform (SIM2l)-overexpressed cells had contrary results, indicating the long isoform plays a key role for maintenance of these phenotypes. These data indicated that SIM2l has a potential to be precision medicine for CvSCC patients and that anti-angiogenesis therapy might be usable for SIM2lLow poor survivors.",
author = "Kanako Nakamura and Masayuki Komatsu and Fumiko Chiwaki and Takashi Takeda and Yusuke Kobayashi and Kouji Banno and Daisuke Aoki and Teruhiko Yoshida and Hiroki Sasaki",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-15261-4",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma

AU - Nakamura, Kanako

AU - Komatsu, Masayuki

AU - Chiwaki, Fumiko

AU - Takeda, Takashi

AU - Kobayashi, Yusuke

AU - Banno, Kouji

AU - Aoki, Daisuke

AU - Yoshida, Teruhiko

AU - Sasaki, Hiroki

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Despite chemoradiotherapy being one of the most important modalities in advanced cervical cancer, there is a lack of both usable biomarkers to predict treatment outcome and of knowledge about the mechanism of refractoriness to the therapy. Here we identified a transcriptional factor Single-minded homolog 2 (SIM2) as an independent predictive biomarker for uterine cervical squamous cell carcinoma (CvSCC). The retrospective study showed that high expression level of SIM2 was correlated to good survival in CvSCC patients. SIM2 knockdown in CvSCC cell lines showed resistance to hypoxia with increased expression of HIF1A and its target genes. Loss of SIM2 also caused growth promotion, resistance to ROS, and radiation in 3D culture. Furthermore, SIM2 knockdown suppressed tumor growth with increased HIF-1α expression and angiogenesis in vivo. On the other hand, SIM2 long isoform (SIM2l)-overexpressed cells had contrary results, indicating the long isoform plays a key role for maintenance of these phenotypes. These data indicated that SIM2l has a potential to be precision medicine for CvSCC patients and that anti-angiogenesis therapy might be usable for SIM2lLow poor survivors.

AB - Despite chemoradiotherapy being one of the most important modalities in advanced cervical cancer, there is a lack of both usable biomarkers to predict treatment outcome and of knowledge about the mechanism of refractoriness to the therapy. Here we identified a transcriptional factor Single-minded homolog 2 (SIM2) as an independent predictive biomarker for uterine cervical squamous cell carcinoma (CvSCC). The retrospective study showed that high expression level of SIM2 was correlated to good survival in CvSCC patients. SIM2 knockdown in CvSCC cell lines showed resistance to hypoxia with increased expression of HIF1A and its target genes. Loss of SIM2 also caused growth promotion, resistance to ROS, and radiation in 3D culture. Furthermore, SIM2 knockdown suppressed tumor growth with increased HIF-1α expression and angiogenesis in vivo. On the other hand, SIM2 long isoform (SIM2l)-overexpressed cells had contrary results, indicating the long isoform plays a key role for maintenance of these phenotypes. These data indicated that SIM2l has a potential to be precision medicine for CvSCC patients and that anti-angiogenesis therapy might be usable for SIM2lLow poor survivors.

UR - http://www.scopus.com/inward/record.url?scp=85032896206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032896206&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-15261-4

DO - 10.1038/s41598-017-15261-4

M3 - Article

C2 - 29109451

AN - SCOPUS:85032896206

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14574

ER -